We might only hypothesize that the existence of a significant difference in ghrelin levels between both groups in our study, despite the absence of obesity or other risk factors for a severe course of the disease, might indicate that during COVID-19 infection, increased ghrelin may contribute, among other factors, to the mild course of the infection, especially in women. This evidence concerns the gene GHRL and obesity disorder.